to quantify health status from the patient's viewpoint without interpretation of responses by the clinician. [73] PROMs quantify treatment impact in three major categories: global health-related quality-of-life (HRQoL), pain, and disease-specific disability. These instruments facilitate a variety of studies, most commonly comparative-and cost-effectiveness research. In addition, PROMs have been used in process improvement, such as identifying mismatches in patient/provider perceptions of health status or assessing the appropriateness of referrals, and they may eventually be used to benchmark clinical centers relative to national averages. [54, 78, 82, 87] PROMs may also be analyzed in conjunction with clinical parameters such as radiographic markers to preoperatively stratify patient selection and predict outcomes. [43, 67] The US government has made research involving PROMs a high priority with the passage of the Patient Protection and Affordable Care Act in 2010 and development of the Patient Centered Outcomes Research Institute. [59, 74] In addition, the UK National Institute for Health and Care Excellence (NICE) has made a collection of PROMs standard practice in four common surgical procedures since 2009. [14] While the number of publications reporting PROMs grows each year, so too has the number of PROMs being used, which leads to confusion on what an instrument actually measures, and which instruments are appropriate to use for various conditions.
In this review, we aim to describe basic concepts associated with PROMs, the most commonly used instruments in spine surgery, and their application for tracking outcomes in a spine practice.
Criteria for evaluating an instrument
For an instrument to become widely adopted, it must generally meet a number of quality control criteria. For brevity, in this review, we have simplified the statistics, broadly terms "psychometrics," presented and their interpretations [ Table 1 ].
Major evaluation criteria include validity, reliability, and responsiveness. [60] Validity assesses how accurately an instrument measures what it intends to measure. A common method of determining validity is by calculating floor and ceiling effects, that is, if ≥15% of respondents achieve the lowest or highest possible scores, validity is considered limited. [55] Reliability measures the reproducibility of an instrument's results. It can be evaluated with a variety of statistics, most commonly Cronbach's α. A Cronbach's α of ≥0.70 is a rule of thumb for acceptable reliability. [81] Finally, responsiveness represents a PROM's ability to detect change. The most common statistic used to evaluate responsiveness is the area under the receiver-operating characteristic curve (AUC). AUC values ≥0.70 are often considered to have acceptable responsiveness. [81] The minimal clinically important difference (MCID) provides a threshold for meaningful change in the value of a statistic and is unique to each instrument, disease state, and patient population being studied. It is calculated based on either sample data distribution (i.e., standard deviation, effect size), "anchor" methods wherein changes in scores are linked to a binary question on whether or not the patient considers himself improved, or by professional consensus. [19] MCIDs are important when interpreting the results of a study, particularly studies with larger sample sizes, as statistically significant differences may arise which are not clinically meaningful.
In the following sections, we detail the more commonly used PROMs in spine surgery [ Tables 2-4 ]. This review is not exhaustive of all instruments employed in the literature, but rather presents those most likely to be encountered by the typical spine surgeon. These instruments have largely been deemed valid, reliable, and responsive, although we have noted perceived limitations when applicable.
GENERIC HEALTH-RELATED QUALITY-OF-LIFE INSTRUMENTS
Generic HRQoL instruments quantify the overall physical, social, and mental well-being of a patient and apply to a range of diseases, not just spinal conditions [ Table 1 ]. The "domains" within a generic HRQoL instrument refer to specific categories of questions, such as those focused on physical functioning or pain; thus, there is overlap with other categories of PROMs. The results of generic HRQoL instruments may be presented as a nominal score without interpretation of the relative weight of each question, or the results may be presented as "utility scores" tied to studies on societal preferences for different health states.
Utility scores generally range from 0 (death) to 1 (perfect health), although negative numbers are also possible and reflect health states considered worse than The minimum change in an outcome instrument score deemed to be clinically significant QALY Quality-adjusted life year
A measure of quality-of-life that is, used in healthcare economic studies, such as cost-effectiveness research death. [85] Utility scores may be reported in conjunction with time to derive quality-adjusted life years (QALYs), the fundamental currency of effectiveness research. QALYs are determined by the change in utility over time multiplied by the time period. It should be noted that the calculation of QALYs relies specifically on utility scores, not nominal HRQoL scores, pain scores, or disease-specific disability scores.
The most commonly used generic HRQoL measures in the spine surgery literature are the EuroQOL-5D (EQ-5D) and the Short Form (SF) instruments.
EuroQOL-5D
The EQ-5D is a preference-based generic HRQoL instrument developed in 1990 by the EuroQOL Group. [25] Utility scores are generated from five questions on mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Scoring of the EQ-5D has been conducted in multiple population samples (US, UK, Dutch, etc.). The minimum and maximum scores of the EQ-5D vary based on the population set being used. For example, UK population utilities range from −0.594 to 1, while US. population utilities range from −0.109 to 1.
There are two versions of the EQ-5D, one with three options for each question (EQ-5D 3L) and one with five options (EQ-5D 5L). The EQ-5D 3L has been the more commonly used of the two and describes 243 possible health states, in addition to death and a comatose state. The second component of both versions of the EQ-5D is a visual analog scale (VAS) where responders are asked to rate their current overall health state as a single mark on a scale from 0 to 100.
Advantages of the EQ-5D include its brevity, applicability to a wide range of diseases, direct utility scoring, and common application in the spine surgery literature. In addition, it has been recommended by the [21, 88] Criticisms of the EQ-5D include it being too simplistic and that it may suffer from ceiling effects. For example, a study by Brazier et al. of nearly 2000 British respondents in the general population found nearly 50% of respondents scored at the ceiling. [10] In addition, within the spine literature, there has been a very wide range of reported MCID values depending on preoperative diagnosis, many of which are multiple times higher than the 0.074 MCID threshold first described by Walters and Brazier in 2005. [63, 64, 85] 
Short-forms
The SF instruments are based on the RAND Corporation's 1989 Medical Outcomes Study. The original survey, a 116-item questionnaire across eight domains on physical functioning, role limitations, health perceptions, vitality, social functioning, mental health, and health transition was consolidated to the more popular 36-item SF-36. [86] The results of the SF-36 are generally reported in terms of the eight separate domain scores and/or two summary scores (physical component summary [PCS] , mental component summary), each of which ranges from 0 to 100. The preference-based SF-6D was subsequently developed to directly generate utility scores, which range from 0.296 to 1. [86] Because of overlapping questions, the SF-36 can be "mapped" to the SF-6D to also derive utility scores.
Advantages of the SF instruments include widespread use, comprehensive sets of questions, and the ability to generate utility scores via the SF-6D. A major disadvantage of the commonly employed SF-36 is that considerably more time and effort is required to complete it compared to the EQ-5D. In addition, most published SF-36 results are presented as domain or summary scores, which cannot reliably be compared to effectiveness research using utility scores. One study specific to cervical spine surgery found considerable floor effects, [5] and there has been some concern that the SF-6D overestimates utility scores, as the lowest score for the SF-6D is 0.296 utility versus negative utility scores for the EQ-5D.
The same 2005 study by Walters et al. on 11 various diseases identified an MCID of 0.041 for SF-6D utility values after an intervention. [85] A commonly used MCID for the SF-36 PCS in spine surgery is 5 points. [18] Finally, it should be noted that although the EQ-5D and SF-6D both derive utility scores, the instruments often generate very different values for the same disease state and should not be used interchangeably. [77] Studies on nonspinal pathology, such as heart disease and osteoarthritis, have reported that utility values significantly vary between instruments. [71, 83] Moreover, small variations in utility may lead to very large differences in the perceived cost-utility of a procedure, which may have implications for health technology assessment and resource allocation.
PAIN PATHOLOGY

Visual analog scale
The VAS is a one-dimensional scale for rating current pain on a continuum. [62] It is typically presented as a 10 centimeter (cm) scale with millimeter (mm) markers, on which the patient can mark any point on the scale. [22] Patients are asked to rate their pain score based on the past 24 hours. The general interpretation is as follows: Advantages of the VAS include brevity, ease for patients and administrators, and comprehensive psychometric assessment. [22, 39, 47, 53] In spine surgery, the VAS is commonly used to separately assess back pain (VAS-BP) and leg pain (VAS-LP). The highly subjective nature of pain limits comparison across a range of patients, however. In addition, it is highly dependent on the patient's short-term experience with pain, rather than a long-term average. Interestingly, slightly lower scores have been reported for horizontally oriented VAS compared to vertical ones. [39] MCID: When studying emergency department patients with acute pain from primarily abdominal, extremity, and back etiologies, Lee et al. found an MCID of 3 mm. [49] Similarly, in patients undergoing surgical decompression and fusion for recurrent lumbar stenosis, Parker et al. found MCIDs of 2.2 and 5 for the VAS-BP and VAS-LP, respectively. [63] Numerical rating scale for pain
The numerical rating scale (NRS) is a one-dimensional scale for rating pain across multiple diseases and is essentially a variation of the VAS. [15, 23, 33] The most common format is a horizontal line with anchors at 0 and 10 (0 = no pain, 10 = worst pain imaginable), in which patients pick a discrete number on the scale (e.g., 3 or 4, not 3.5). [22, 40] Like the VAS, most providers ask patients to rate their pain over the previous 24 hours.
Advantages of the NRS include brevity and published psychometrics. [22, 29, 40, 41] In addition, one study found higher rates of data completion using the NRS compared to the VAS. [23] The primary criticism of the NRS, like the VAS, is that one-dimensional instruments fail to capture the true experience of pain and can mislead providers regarding patient outcomes. [38] MCID: When studying the NRS using a 0-10 scale in clinical trials for diabetic neuropathy, postherpetic neuralgia, chronic low BP, fibromyalgia, and osteoarthritis, Farrar et al. found a change of 2 points to be clinically meaningful. [28] Similar results were found when using a 15-point scale for patients with low BP. [15] McGill Pain Questionnaire
The McGill Pain Questionnaire (MPQ) was introduced in 1975, with a shorter version (SF-MPQ) developed in 1987. [57, 58] The SF-MPQ measures pain experience using three components: A list of 15 pain descriptors, a "present pain intensity (PPI)" index, and a VAS. Each of the pain descriptors is assigned to progressive levels of pain (0 = none, 1 = mild, 2 = moderate, 3 = severe). In 2009, the SF-MPQ was modified (SF-MPQ-2) to include an additional seven neuropathic-specific markers and more responsive scoring methodology. [24] The SF-MPQ-2 also changed the answer range for each descriptor to 0-10 (0 = none, 10 = worst possible).
The SF-MPQ is scored from 0 to 45 for the pain descriptors, 0-5 for the PPI index, and on a continuum for the VAS. These values can be used as individual measures for each component or summed for total pain score. The scoring is slightly different for the SF-MPQ-2 because patients select a value from 0 to 10 for each descriptor, resulting in a pain descriptor range of 0-220. [24] Advantages of the SF-MPQ are its comprehensiveness, ease of completion, and psychometric assessment. [13, 32, 50, 79] However, Grafton et al. found that supervision and guidance are still needed for new users to adequately complete the SF-MPQ. [32] MCID: Strand et al. found an MCID of >5 points on the 0-45 scale for patients with rheumatoid and musculoskeletal pain. [79] In the osteoarthritis population, Grafton et al. found an MCID of 5.2 for the total score, 4.5 for the sensory descriptors, 2.8 for the affective descriptors, 1.4 for the PPI, and 1.4 for the VAS. [32] LUMBAR SPINE PATHOLOGY
Oswestry disability index
The Oswestry disability index (ODI) was first described in 1980 and measures functional disability from low BP. [26] It has become the most widely used PROM for BP and is most sensitive in patients with severe pain. It consists of 10 items related to everyday activities using a series of six short descriptions of progressively worse disability.
The ODI is scored from 0 to 100 (0 = no pain/disability, 100 = immobilizing pain/disability). Scoring is completed by summing the answers for each question on a 0-5 scale, dividing by the total possible score, and then multiplying by 100. Up to two questions may be omitted with preserved validity. The general interpretation of scores is as follows: The advantages of the ODI are simplicity, brevity, widespread use, psychometric validation, and sensitivity for higher levels of disability. [27] One disadvantage is that the ODI is relatively insensitive in patients with mild pain/disability compared to other instruments. In addition, the ODI is difficult to administer over the phone due to the length of the answer choices.
MCID: Using outcomes from the Lumbar Spine Study Group, Copay et al. determined an MCID of 12.8 for the ODI. [18, 56] The Food and Drug Administration considers an MCID of 15 for patients undergoing spinal fusion. [27] 
Roland-Morris Disability Questionnaire
The Roland-Morris Disability Questionnaire (RMDQ) was developed in 1983, and unlike the ODI, is more sensitive in patients with mild/moderate BP. [69, 70] It consists of 24 yes/no questions that begin with "because of my back pain." Answers of "yes" indicate pain or disability. The RMDQ is scored from 0 to 24 by summing the number of "yes" responses to the 24 questions. Zero is considered no disability and 24 to be an immobilizing disability.
Advantages of the RMDQ are sensitivity to milder levels of low BP, simplicity, widespread use, and psychometric assessment. [9, 42, 48, 51, 65, 69] Disadvantages include its length compared to the ODI, and that it does not address psychological or social disability. However, most patients complete the RMDQ in <5 minutes on average, despite having more than twice the questions of the ODI. [68] [69] [70] MCID: After conducting a review of studies that used the RMDQ, Roland and Fairbank concluded that the MCID is between 2.5 and 5, depending on baseline disability. [68] Stratford et al. found MCIDs of 1-2 for patients with mild baseline disability, 7-8 for patients with moderate to severe baseline disability, and 5 for patients without a previous disability selection. [80] 
Quebec Back Pain Disability Scale
The Quebec Back Pain Disability Scale (QBPDS) was introduced in 1996 to quantify functional disability from BP. [45] The survey consists of 20 questions across six categories: Bed and rest, sitting and standing, ambulation, movement, bending, and handling of large items. Each question is rated on a 6-item Likert scale ranging from "not difficult at all" (0) to "unable to do" (5). The total is summed to produce a score from 0 to 100, where 0 is no disability and 100 is complete disability.
Advantages of the QBPDS are brevity, sensitivity to pelvic girdle pain and disability, and psychometric validation. [45, 46, 72] The primary disadvantage is that it is not widely used in the spinal surgery literature, and there are concerns that it is not as reliable as the ODI. [30] MCID: In patients receiving physical therapy for BP, Davidson and Keating found an MCID of 19, while Fritz and Irrgang found an MCID of 15 in similar patients undergoing physical therapy. [20, 30] 
Japanese Orthopedic Association Back Pain Evaluation Questionnaire
The Japanese Orthopedic Association Back Pain Evaluation Questionnaire (JOABPEQ) was first described in 2007 to measure functional disability due to low BP. [31] It consists of 25 questions across five categories: Low BP, lumbar function, walking ability, social life function, and mental health. Answers choices are either yes/no or on a Likert scale. Scoring is completed using a unique weighting methodology for each answer and sub-category, the algorithm for which is available on the JOA website. The total score ranges from 0 to 20 for each of the five categories, with lower scores indicating more severe disability. The survey is not designed to produce an aggregate score of the five categories.
Advantages of the JOABPEQ include its breadth of measurement for each domain, weighting of questions, and psychometric validation. [4, 31] However, these same benefits make the questionnaire much longer for patients to complete and more difficult to score and interpret. In addition, it is not widely used in the spine surgery literature.
MCID: Not determined.
CERVICAL SPINE PATHOLOGY
Neck disability index
The Neck disability index (NDI) was developed in 1991 as a modification of the ODI and serves to quantify disability due to neck pain. [84] It consists of 10 items related to pain, personal care, lifting, reading, headaches, concentration, work, driving, sleeping, and recreation. Each question is scored from 0 (no disability) to 5 (complete disability) and is then totaled (0-50). The score may be reported as either a raw score or percentage. If more than two questions are unanswered, the survey may no longer be valid. The general interpretation of scores is as follows: Advantages of the NDI include simplicity, brevity, widespread use, and durability. It does not appear to suffer from floor or ceiling effects when used as intended, although floor and ceiling effects were observed when attempts were made to map the NDI to the SF-6D. [66] One disadvantage is that there is no incorporation of medication use in the scoring.
MCID: Auffinger et al. found an MCID of 2.41 points following surgical treatment of degenerative cervical spine disease. [2] Carreon et al. found an MCID of 7.5 points following cervical fusion surgery, Cleland et al. found an MCID of 19% (9.5 points) in nonoperative neck pain patients undergoing physical therapy, and Auffinger et al. found an MCID of 13.39 points in surgically treated cervical myelopathy patients. [3, 11, 17] The wide range of reported MCIDs, differences in study methodology, and range of sample sizes make MCID cut-offs difficult for this instrument.
Cervical Spine Outcomes Questionnaire
The Cervical Spine Outcomes Questionnaire (CSOQ) was developed in 2002 as a disease-specific measure of disability from cervical spine pathology. [7] 35 items are presented over six domains on neck pain, shoulder/arm pain, functional disability, psychological distress, physical symptoms, and healthcare utilization. The individual domains are scaled from 0 to 100 and intended for individual comparison rather than a cumulative score.
Advantages include published psychometrics, differentiation between neck and extremity pain, and the incorporation of pain medication use in the score. [76] Disadvantages include ceiling effects in physical symptoms, [76] and more importantly, it is uncommonly used and difficult to obtain (both the survey and scoring algorithm). In addition, it requires more time and effort by patients to complete compared to the NDI. The original survey was developed using surgical patients; thus, it may not be generalizable to nonsurgical patients, and details of the scoring and weighting processes are unclear from the original manuscript.
MCID: Skolasky et al. assessed the CSOQ on anterior cervical discectomy and fusion patients and found MCIDs of 0.13-0.24 for the various domains. [75] It should be noted that scores for the CSOQ in that study appear to be on a 0-1 scale, rather than the 0-100 scale originally described.
Modified Japanese Orthopedic Association Scale
The Japanese Orthopedic Association Scale (JOA) was developed in 1985 to quantify the severity of cervical myelopathy. [36] It consists of 6 items in three domains: Motor function (upper extremity, lower extremity), sensory function (upper extremity, trunk, lower extremity), and bladder function. Because the original survey is geared toward a Japanese audience (e.g., upper extremity dysfunction is evaluated by the ability to use chopsticks), it was modified in 1991 by Benzel et al. to consolidate the survey to four questions and contextually translate it for Western audiences. [8] The second modification was introduced by Chiles et al. that reverted to the original 6 items while maintaining the Western contextual translation, [16] although Benzel's version remains the more commonly used.
Scoring depends on which modified JOA (mJOA) version is used; both versions are additive, but Benzel's version is scored out of 18 total points, while the Chiles version is scored out of 17 points. Lower scores indicate more severe myelopathy. Although there are no formal strata, the literature suggests scores >12 indicate mild myelopathy. [52] Advantages of the mJOA are simplicity, brevity, widespread use, and durability. The primary disadvantage is that it has never been psychometrically validated despite widespread acceptance and recommendation by professional societies.
Myelopathy disability index
The myelopathy disability index was developed in 1996 as a modified version of the Stanford Health Assessment Questionnaire. [12] It was designed to evaluate the degree of cervical myelopathy in rheumatoid arthritis patients undergoing surgical intervention for cervical myelopathy. The survey has 10 items regarding standing, walking, grip strength, eating, and hygiene, each with four choices (0-3). The results are additive (maximum score of 30), with the final score generally expressed as a percentage. Higher scores indicate more severe myelopathy.
Advantages include its brevity and psychometric validation. [12] However, it is not commonly used compared to the mJOA scale and seems to have fallen out of favor in recent years.
Finally, the Nurick scale is a common instrument for assessing cervical myelopathy. While some may interpret the Nurick scale as a PROM, it is a physicianassigned instrument, as lower grades on the scale are based on signs of root or cord involvement rather than patient-endorsed symptoms.
COSTS
A brief overview on costs is relevant given the intrinsic relationship between PROMs and cost-effectiveness research. There are three principal types of costs: Direct costs (e.g., physician time and labor, cost of operating room, length of stay, etc.), indirect costs (e.g., lost productivity from missed work days), and intangible costs (e.g., pain and suffering). For the purposes of cost-utility analysis in spine surgery, most researchers attempt to use a "societal perspective," which is the sum of all direct and indirect costs.
Direct costs include inpatient hospital costs, outpatient expenses, and physician professional fees. There are numerous methods with which to estimate costs, most of which rely on hospital charge data, hospital reimbursement data, or average payer reimbursement rates. [1] Unfortunately, methods of estimating costs are often imprecise and may yield highly discrepant data, particularly between countries with varying health care systems. For example, Whitmore et al. compared estimated direct hospital costs for the surgical treatment of cervical myelopathy in US patients using two methods: (1) Based on hospital charge data, and (2) based on average Medicare reimbursements. [90] For dorsal surgery, the estimated cost of the index hospitalization using the first method was nearly $11,000 higher than the second method. In addition, dorsal procedures appeared to be more expensive than ventral procedures in the first method, while the second method suggested the opposite. The authors concluded that the choice of cost methodology substantially affects the final results of cost-utility studies.
Additional costs that are often overlooked include re-admission/re-operation and outpatient expenses. Patients may be re-admitted for a variety of reasons, such as a deep vein thrombosis requiring treatment, or may require early or delayed re-operation for reasons related to the index procedure, such as postoperative hematoma or hardware failure. These complications can multiply the aggregate costs of care. Therefore, data related to re-operation and re-admission should be tracked prospectively. Outpatient expenses, such as physical therapy, medication use, and radiographic screening, may become substantial yet are frequently omitted due to the difficulties in accurately tracking outpatient resource utilization. With regard to indirect costs, time off from work is the central variable and should ideally be tracked prospectively to minimize recall bias. Indirect costs are estimated by multiplying a patient's wages by time off from work, although national wage indices are often used as a proxy if actual wage data are unavailable.
Once both costs and outcomes (QALYs) are measured, the results may be presented as the cost per QALY gained for a given procedure. When comparing two procedures, the incremental cost-effectiveness ratio (ICER) can be obtained using the formula: (Cost of treatment A−Cost of Treatment B)/(QALY of treatment A−QALY of treatment B). Lower ratios imply better cost-effectiveness. The ICER needs to be interpreted in the context of society's willingness to pay. Previous studies have suggested a seemingly arbitrary cost-effectiveness ratio <$50,000/QALY as acceptable in many developed countries, although the figure is highly contentious, with some authors suggesting significantly less, others significantly more, and some concluding a mismatch between willingness to pay theory and usefulness in actual practice. [34, 44, 61] 
DISCUSSION
Given the focus on patient-centered medical care and increased attention to the value of healthcare, PROMs will be increasingly used in clinical research moving forward. These instruments attempt to quantify and provide uniformity in evaluating characteristics that clinicians have traditionally assessed subjectively. While they are imperfect, PROMs are the building blocks for our ability to improve care and assess the impact of surgical interventions from a patient's perspective.
The choice of instrument selection depends on several factors, including psychometric evaluation, practicality to the patient, administrative burden, use in published literature, and professional consensus, among others. Most spinal diseases cause a combination of pain and disability, which in turn affects QoL. Thus, at least one instrument from each major category should be employed in the evaluation of spine patients. In nonspinal diseases, however, the core pathology may be completely asymptomatic yet still require treatment (e.g., unruptured intracranial aneurysms). In such patient population, determining the appropriate outcome measures can be more challenging. Instruments should be administered preoperatively and at scheduled time points postoperatively. Preoperative baseline values and serial postoperative scores are particularly important for generic HRQoL instruments because determining QALYs requires both time points and is essential for conducting comparative-and cost-effectiveness research.
Patient and administrative burden is particularly important to consider with the rise of prospective registries, in which patients are followed for long periods of time postoperatively. Longer surveys have been shown to have lower completion rates, which detract from the overall quality of data. [6, 35] Perhaps for that reason, the EQ-5D has been adopted as the generic HRQoL outcome for both the National Neurosurgery Quality and Outcomes Database and the UK NICE quality improvement initiative, and will likely become even more commonly encountered in the future. [14, 54] Finally, it should be re-iterated that SF-6D and EQ-5D surveys often derive very different utility values for the same condition, thus when comparing multiple studies for a given disease or surgery, it is important to keep in mind which instrument was employed. [89] For disease-specific instruments, the MCID, if determined, should be considered when evaluating outcomes. Although there may be statistically significant changes detected following an intervention, it may not be clinically meaningful. Most studies on MCID have used very specific patient population with small sample sizes; thus, the MCIDs published to date need to be interpreted with caution. In addition, it should be noted that some disease-specific instruments that are widely accepted and commonly used may have not have undergone rigorous psychometric assessment, an opportunity for future research. Finally, while they do quantify treatment effect, QALYs are not derived from disease-specific instruments, and, therefore, cannot be relied upon for cost-utility studies.
Moving forward, increased uniformity among PROMs in published studies would improve the comparability within health services research. Furthermore, there is a continued need for disease-specific instruments for common subsets of spine surgery patients, most notably radiculopathy. Most cases of radiculopathy do not require surgery, and given the highly subjective nature of pain, it is difficult to track the true functional debilitation from radiculopathy aside from proxy use of the ODI/NDI or HRQoL instruments. The US National Institutes of Health recently allocated resources for the development of new, validated PROMs through a program entitled PROM Information Systems (PROMIS), which uses item response theory to develop shorter, psychometrically validated instruments. One recent study has already found the PROMIS physical functioning survey to be appropriate in patients with degenerative spine conditions. [37] However, it will be interesting to see whether this program consolidates the plethora of instruments currently in use or only expands it.
CONCLUSION
PROMs measure important aspects of disease burden from a patient's perspective. While traditional outcomes measures in spine surgery have relied on clinical data, radiographic studies, and physician-assigned scales, there has been an increasing trend for the use of PROMs in routine clinical practice, which will likely become standard of care in the future. The broad categories of PROMs include generic HRQoL, pain, and disease-specific disability, all of which should be measured preoperatively and at regular intervals postoperatively to obtain a comprehensive assessment of the patient's condition. The foremost goal is to select appropriate instruments given the patient's underlying condition, but one should also keep in mind the sustainability of measuring outcomes from patient burden and administrative standpoints. In addition, the accurate estimation of costs is a challenging but necessary task as increased attention is paid to the relative value of surgical interventions.
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